Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015¿2020 Mark G. Wise; James A. Karlowsky; Elkin V. Lemos-Luengas; Rafael R. Valdez; Daniel F. Sahm;

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018¿2020 James A. Karlowsky; Sibylle H. Lob; Fakhar Siddiqui; Jacqueline Pavia; C. Andrew DeRyke; Katherine Young; Mary R. Motyl; Daniel F. Sahm;

Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil Zuleica Naomi Tano; Renata K. Kobayashi; Evelyn Poliana Candido; Juliana Buck Dias; Luis Felipe Perugini; Eliana Carolina Vespero; Wander Rogerio Pavanelli;